GBS Inc. (NYSE:GBS – Get Free Report)’s share price traded down 5.9% during mid-day trading on Monday . The company traded as low as $1.58 and last traded at $1.59. 160,598 shares changed hands during trading, a decline of 83% from the average session volume of 955,325 shares. The stock had previously closed at $1.69.
GBS Trading Up 3.4 %
The firm’s 50-day simple moving average is $1.46 and its 200 day simple moving average is $2.09. The stock has a market cap of $22.78 million, a P/E ratio of -2.73 and a beta of 1.32.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Featured Articles
- Five stocks we like better than GBS
- EV Stocks and How to Profit from Them
- 3 Momentum Trades for October With Ample Upside Ahead
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- What Are Dividend Champions? How to Invest in the Champions
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
